ASGCT To Honor Four Ground-Breaking Researchers at 21st Annual Meeting – PR Web (press release)
PR Web (press release) |
ASGCT To Honor Four Ground-Breaking Researchers at 21st Annual Meeting
PR Web (press release) The American Society of Gene and Cell Therapy (ASGCT) will honor four groundbreaking researchers and advocates as part of the Society’s 21st Annual Meeting, held at the Chicago Hilton this week. The presentation of these four awards represents the … |
Xconomy |
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
Xconomy Xconomy Boston —. The founders of CRISPR-Cas9 startup Editas Medicine have gotten a jump on the next version of CRISPR gene editing. Scientists from Harvard University, Massachusetts General Hospital, and the Broad Institute are behind Beam … Feng Zhang’s base-editing CRISPR startup officially launches with $87MFierceBiotech A pencil, not a pair of scissors: CRISPR pioneers’ new company bets on base editing to cure diseaseSTAT CRISPR trailblazers Zhang, Liu and Joung join forces to launch Beam with $87M and cutting-edge gene-editing techEndpoints News MIT Technology Review –Financial Times –Business Insider all 9 news articles » |
Chemical & Engineering News |
David Liu launches Beam Therapeutics to treat genetic diseases …
Chemical & Engineering News Beam CEO John Evans and the firm’s three cofounders, David Liu, Keith Joung, and Feng Zhang. When David R. Liu debuted his base editors, a modified form … Beam Therapeutics lasers in on $87m series A · Articles · Global …Global University Venturing |
STAT |
A pencil, not a pair of scissors: CRISPR pioneers’ new company bets on base editing to cure disease
STAT onths after its dozen scientists began working in secret on what’s been called “the most clever CRISPR gadget” so far, the latest company hoping to deploy genome-editing to cure diseases came out of stealth mode on Monday. Beam Therapeutics, which … |
FierceBiotech |
Feng Zhang’s base-editing CRISPR startup officially launches with $87M
FierceBiotech Feng Zhang’s latest CRISPR company, Beam Therapeutics officially came out of stealth Monday, with $87 million in series A funding and a mission to develop “precision genetic medicines” that use CRISPR technology to edit just one nucleotide base, … CRISPR trailblazers Zhang, Liu and Joung join forces to launch Beam with $87M and cutting-edge gene-editing techEndpoints News Harvard and MIT launch gene editing companyFinancial Times A startup that wants to make treatments that edit single letters in our DNA just raised $87 millionBusiness Insider Business Wire (press release) –Harvard Gazette all 6 news articles » |